Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites

Plasmodium falciparum and Plasmodium vivax cause the majority of human malaria cases. Research efforts predominantly focus on P. falciparum because of the clinical severity of infection and associated mortality rates. However, P. vivax malaria affects more people in a wider global range. Furthermore, unlike P. falciparum, P. vivax can persist in the liver as dormant hypnozoites that can be activated weeks to years after primary infection, causing relapse of symptomatic blood stages. This feature makes P. vivax unique and difficult to eliminate with the standard tools of vector control and treatment of symptomatic blood stage infection with antimalarial drugs. Infection by Plasmodium is initiated by the mosquito-transmitted sporozoite stage, a highly motile invasive cell that targets hepatocytes in the liver. The most advanced malaria vaccine for P. falciparum (RTS,S, a subunit vaccine containing of a portion of the major sporozoite surface protein) conferred limited protection in Phase III trials, falling short of WHO-established vaccine efficacy goals. However, blocking the sporozoite stage of infection in P. vivax, before the establishment of the chronic liver infection, might be an effective malaria vaccine strategy to reduce the occurrence of relapsing blood stages. It is also thought that a multivalent vaccine comprising multiple sporozoite surface antigens will provide better protection, but a comprehensive analysis of proteins in P. vivax sporozoites is not available. To inform sporozoite-based vaccine development, we employed mass spectrometry-based proteomics to identify nearly 2,000 proteins present in P. vivax salivary gland sporozoites. Analysis of protein post-translational modifications revealed extensive phosphorylation of glideosome proteins as well as regulators of transcription and translation. Additionally, the sporozoite surface proteins CSP and TRAP, which were recently discovered to be glycosylated in P. falciparum salivary gland sporozoites, were also observed to be similarly modified in P. vivax sporozoites. Quantitative comparison of the P. vivax and P. falciparum salivary gland sporozoite proteomes revealed a high degree of similarity in protein expression levels, including among invasion-related proteins. Nevertheless, orthologs with significantly different expression levels between the two species could be identified, as well as highly abundant, species-specific proteins with no known orthologs. Finally, we employed chemical labeling of live sporozoites to isolate and identify 36 proteins that are putatively surface-exposed on P. vivax salivary gland sporozoites. In addition to identifying conserved sporozoite surface proteins identified by similar analyses of other Plasmodium species, our analysis identified several as-yet uncharacterized proteins, including a putative 6-Cys protein with no known ortholog in P. falciparum.

[1]  J. Baird.  Eliminating malaria—all of them , 2010, The Lancet.

[2]  K. Julenius.  NetCGlyc 1.0: prediction of mammalian C-mannosylation sites. , 2007, Glycobiology.

[3]  K. Resing,et al.  Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics*S , 2005, Molecular & Cellular Proteomics.

[4]  Kristian E. Swearingen,et al.  Total and Putative Surface Proteomics of Malaria Parasite Salivary Gland Sporozoites* , 2013, Molecular & Cellular Proteomics.

[5]  Luis Mendoza,et al.  Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics , 2015, Proteomics. Clinical applications.

[6]  Erika L. Flannery,et al.  Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and potential mechanisms for liver-stage differentiation , 2018, bioRxiv.

[7]  Michael B. Doud,et al.  Unexpected fold in the circumsporozoite protein target of malaria vaccines , 2012, Proceedings of the National Academy of Sciences.

[8]  Eileen Kraemer,et al.  PlasmoDB: a functional genomic database for malaria parasites , 2008, Nucleic Acids Res..

[9]  K. Miura,et al.  Functional Analysis of the Leading Malaria Vaccine Candidate AMA-1 Reveals an Essential Role for the Cytoplasmic Domain in the Invasion Process , 2009, PLoS pathogens.

[10]  J F Vliegenthart,et al.  New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. , 1994, Biochemistry.

[11]  Joshua E Elias,et al.  The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. , 2011, Cell host & microbe.

[12]  A. Tobin,et al.  Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. , 2011, Nature communications.

[13]  Vasant G Honavar,et al.  PlasmoSEP: Predicting surface-exposed proteins on the malaria parasite using semisupervised self-training and expert-annotated data , 2016, Proteomics.

[14]  S. Hoffman,et al.  Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[15]  M. Sternberg,et al.  Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls , 2012, Parasitology.

[16]  S. Kappe,et al.  SSP3 Is a Novel Plasmodium yoelii Sporozoite Surface Protein with a Role in Gliding Motility , 2014, Infection and Immunity.

[17]  Sugar activation and glycosylation in Plasmodium , 2015, Malaria Journal.

[18]  S. Ralph,et al.  Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum , 2012, Genome Biology.

[19]  John R. Yates,et al.  Direct Detection of Biotinylated Proteins by Mass Spectrometry , 2014, Journal of proteome research.

[20]  T. Richie,et al.  Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial , 2016, PLoS neglected tropical diseases.

[21]  N. Waters,et al.  Targeting protein kinases in the malaria parasite: update of an antimalarial drug target. , 2012, Current topics in medicinal chemistry.

[22]  John R Yates,et al.  A Comprehensive Survey of the Plasmodium Life Cycle by Genomic, Transcriptomic, and Proteomic Analyses , 2005, Science.

[23]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[24]  L. Aravind,et al.  Structure of the Plasmodium 6-cysteine s48/45 domain , 2012, Proceedings of the National Academy of Sciences.

[25]  S. Brunak,et al.  SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.

[26]  A. Holder,et al.  The Plasmodium falciparum schizont phosphoproteome reveals extensive phosphatidylinositol and cAMP-protein kinase A signaling. , 2012, Journal of proteome research.

[27]  J. Martínez-Barnetche,et al.  Conserved peptide sequences bind to actin and enolase on the surface of Plasmodium berghei ookinetes , 2011, Parasitology.

[28]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[29]  J. Leigh,et al.  Comparison of spectral counting and metabolic stable isotope labeling for use with quantitative microbial proteomics. , 2006, The Analyst.

[30]  Edward L Huttlin,et al.  Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. , 2013, Journal of proteome research.

[31]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[32]  M. White,et al.  Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses , 2017, Trends in parasitology.

[33]  Alexey I Nesvizhskii,et al.  Abacus: A computational tool for extracting and pre‐processing spectral count data for label‐free quantitative proteomic analysis , 2011, Proteomics.

[34]  J. Eng,et al.  Comet: An open‐source MS/MS sequence database search tool , 2013, Proteomics.

[35]  F. Frischknecht,et al.  Critical Role for Heat Shock Protein 20 (HSP20) in Migration of Malarial Sporozoites* , 2011, The Journal of Biological Chemistry.

[36]  Lauren W. Wang,et al.  Post-translational Modification of Thrombospondin Type-1 Repeats in ADAMTS-like 1/Punctin-1 by C-Mannosylation of Tryptophan* , 2009, The Journal of Biological Chemistry.

[37]  M. Grainger,et al.  Extensive differential protein phosphorylation as intraerythrocytic Plasmodium falciparum schizonts develop into extracellular invasive merozoites , 2015, Proteomics.

[38]  Jetsumon Sattabongkot,et al.  Determination of the Plasmodium vivax schizont stage proteome. , 2011, Journal of proteomics.

[39]  Kristian E. Swearingen,et al.  Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics , 2016, PLoS pathogens.

[40]  C. Ockenhouse,et al.  The RTS,S vaccine candidate for malaria , 2011, Expert review of vaccines.

[41]  A. Vaughan,et al.  A rapid and scalable density gradient purification method for Plasmodium sporozoites , 2012, Malaria Journal.

[42]  Satish Mishra,et al.  A Novel and Conserved Plasmodium Sporozoite Membrane Protein SPELD is Required for Maturation of Exo-erythrocytic Forms , 2017, Scientific Reports.

[43]  John R Yates,et al.  Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. , 2004, Molecular and biochemical parasitology.

[44]  K. Garcia,et al.  Structural basis for Notch1 engagement of Delta-like 4 , 2015, Science.

[45]  J. V. Staros,et al.  N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. , 1982, Biochemistry.

[46]  R. Price,et al.  A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes , 2016, Wellcome open research.

[47]  Kristian E. Swearingen,et al.  Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and potential mechanisms for liver-stage differentiation , 2017, bioRxiv.

[48]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[49]  A. Sicard,et al.  Malaria: targeting parasite and host cell kinomes. , 2010, Biochimica et biophysica acta.

[50]  R. Price,et al.  New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance , 2009, Current opinion in infectious diseases.

[51]  Edwin Lasonder,et al.  Protein Export Marks the Early Phase of Gametocytogenesis of the Human Malaria Parasite Plasmodium falciparum* , 2010, Molecular & Cellular Proteomics.

[52]  P. Zipfel,et al.  Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut. , 2013, Cell host & microbe.

[53]  M. Davenport,et al.  Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo , 2015, PLoS neglected tropical diseases.

[54]  R. Tewari,et al.  An Apicomplexan Actin-Binding Protein Serves as a Connector and Lipid Sensor to Coordinate Motility and Invasion. , 2016, Cell host & microbe.

[55]  David L. Tabb,et al.  A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.

[56]  N. White,et al.  Chapter Two - Relapse , 2012 .

[57]  Robert Burke,et al.  ProteoWizard: open source software for rapid proteomics tools development , 2008, Bioinform..

[58]  Jonathan Crabtree,et al.  Comparative genomics of the neglected human malaria parasite Plasmodium vivax , 2008, Nature.

[59]  N. White.  Determinants of relapse periodicity in Plasmodium vivax malaria , 2011, Malaria Journal.

[60]  Patricia De la Vega,et al.  Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle , 2003, Science.

[61]  B. Maček,et al.  C-Mannosylation and O-Fucosylation of the Thrombospondin Type 1 Module* , 2001, The Journal of Biological Chemistry.

[62]  Bart Barrell,et al.  A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax , 2001, Nature.

[63]  Utpal Tatu,et al.  A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax , 2009, Proteomics. Clinical applications.

[64]  T. Springer,et al.  Structures of the Toxoplasma gliding motility adhesin , 2014, Proceedings of the National Academy of Sciences.

[65]  M. Patarroyo,et al.  Determining the Plasmodium vivax VCG-1 strain blood stage proteome. , 2015, Journal of proteomics.

[66]  H. Ishida,et al.  Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain. , 2006, Glycobiology.

[67]  Eric W. Deutsch,et al.  Combining Results of Multiple Search Engines in Proteomics* , 2013, Molecular & Cellular Proteomics.

[68]  T. Bousema,et al.  Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes: molecular insight into sex-specific processes and translational repression , 2016, Nucleic acids research.

[69]  S. Thiberge,et al.  Apical membrane antigen 1 mediates apicomplexan parasite attachment but is dispensable for host cell invasion , 2013, Nature Communications.

[70]  Benjamin F. Cravatt,et al.  Global Profiling of Proteolysis during Rupture of Plasmodium falciparum from the Host Erythrocyte , 2010, Molecular & Cellular Proteomics.

[71]  Xiaofang Jiang,et al.  Genome analysis of a major urban malaria vector mosquito, Anopheles stephensi , 2014, Genome Biology.

[72]  Hyung-Hwan Kim,et al.  Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivax , 2011, Parasitology Research.

[73]  Richard D. Smith,et al.  Normalization and missing value imputation for label-free LC-MS analysis , 2012, BMC Bioinformatics.

[74]  L. Meijer,et al.  Antimalarial drug discovery: targeting protein kinases , 2007, Expert opinion on therapeutic targets.

[75]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[76]  Martijn A. Huynen,et al.  Proteomic Profiling of Plasmodium Sporozoite Maturation Identifies New Proteins Essential for Parasite Development and Infectivity , 2008, PLoS pathogens.

[77]  R. Price,et al.  Primaquine radical cure of Plasmodium vivax: a critical review of the literature , 2012, Malaria Journal.

[78]  Yi Zhang,et al.  Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP* , 2010, The Journal of Biological Chemistry.

[79]  N. Waters,et al.  Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax , 2017, PLoS neglected tropical diseases.

[80]  T. Springer,et al.  Shape change in the receptor for gliding motility in Plasmodium sporozoites , 2012, Proceedings of the National Academy of Sciences.

[81]  J. Baird,et al.  Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. , 2010, Trends in parasitology.

[82]  Joshua D. Hartzell,et al.  Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy , 2016, PLoS neglected tropical diseases.

[83]  Pier Luigi Martelli,et al.  PredGPI: a GPI-anchor predictor , 2008, BMC Bioinformatics.

[84]  M. Washburn,et al.  Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. , 2010, Analytical chemistry.

[85]  David C Muddiman,et al.  Evaluation of Normalization Methods on GeLC-MS/MS Label-Free Spectral Counting Data to Correct for Variation during Proteomic Workflows , 2011, Journal of the American Society for Mass Spectrometry.

[86]  Michael K. Coleman,et al.  Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. , 2006, Journal of proteome research.

[87]  A. W. Woodruff,et al.  Advances in Parasitology , 2019, Highlighting Operational and Implementation Research for Control of Helminthiasis.

[88]  B. Maček,et al.  Direct determination of glycosylation sites in O-fucosylated glycopeptides using nano-electrospray quadrupole time-of-flight mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.

[89]  Sandra Gesing,et al.  VectorBase: an updated bioinformatics resource for invertebrate vectors and other organisms related with human diseases , 2014, Nucleic Acids Res..

[90]  W. Mccarthy,et al.  Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. , 2013, The New England journal of medicine.

[91]  J. Hofsteenge,et al.  Identification and Characterization of aβ1,3-Glucosyltransferase That Synthesizes the Glc-β1,3-Fuc Disaccharide on Thrombospondin Type 1 Repeats* , 2006, Journal of Biological Chemistry.